DEPO Financial Facts

Total selling, general and administrative expense: 32.57M
Research and development expense: 1.4M
See Full Income Statement

Accumulated other comprehensive gain: -18K
Other current liabilities: 649K
See Full Balance Sheet

DepoMed Inc. (DEPO) Earnings

  |   Expand Research on DEPO
Next EPS Date 11/5/14 *Est. EPS Growth Rate -200.0% *Last Qtr.
Average EPS % Beat Rate +196.9% Revenue Growth Rate +125.7% *Last Qtr.
Average % Move 1-Wk after EPS +2.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/6/14 Q214 -$0.01-$0.08 +$0.07$67.7M$38.03M = Details
5/8/14 Q114 $0.30$0.10 +$0.20$76.54M$53.57M = Details
3/6/14 Q413 $0.72-$0.21 +$0.93$18.79M$19.06M = Details
11/5/13 Q313 $0.11$0.07 +$0.04$37.5M$35.55M = Details
8/7/13 Q213 $0.01-$0.05 +$0.06$30M$29.87M = Details
5/8/13 Q113 -$0.10-$0.06 -$0.04$26.2M$28.93M = Details
2/20/13 Q412 -$0.07-$0.11 +$0.04$26.6M$26.48M = Details
11/5/12 Q312 -$0.03-$0.09 +$0.06$33.3M$30.47M N/A Details